GE HealthCare has secured the US Food and Drug Administration (FDA) granting 510(k) clearance for its Aurora nuclear medicine system and Clarify DL.
The advanced SPECT/CT solutions are designed to enhance diagnostic capabilities and streamline workflows, offering clinicians superior image quality and operational efficiency.
Aurora aims to address the evolving needs of clinicians by providing imaging precision, streamlining workflows, and enhancing patient experience.
The system features a 40mm detector, which offers twice the detector coverage compared to CTs of other hybrid systems, and 128-slice plus intelligent imaging capabilities.
It supports diverse clinical applications, including cardiology, oncology, and neurology.
Aurora’s 5/8-inch crystal NaI detectors make it compatible with various clinical radiopharmaceuticals, including those in the rapidly evolving field of theranostics.
GE HealthCare molecular imaging and computed tomography president and CEO Jean-Luc Procaccin said: “Aurora and Clarify DL are powerful reflections of GE HealthCare’s ongoing investment in next-generation imaging solutions that empower clinicians to practice precision medicine and make more informed decisions.
“By providing diagnostic precision while enabling improved workflow, these nuclear medicine technologies allow clinicians to deliver effective, patient-centred care, ultimately helping drive better outcomes.
“We are proud to be a leader in nuclear medicine and AI technologies and excited to make Aurora with Clarify DL available to healthcare systems, like University Hospitals, and clinicians throughout the United States.”
Clarify DL is designed to complement the Aurora system and provides superior image quality without increasing the injected dose or scan time.
Using advanced deep learning technology, Clarify DL enhances bone SPECT image quality, providing clear and accurate imaging that boosts diagnostic confidence.
In clinical evaluations, Clarify DL’s image resolution was rated as superior in 98% of exams, highlighting its potential to transform nuclear medicine bone SPECT imaging diagnostics.
Unlike traditional noise reduction techniques that may compromise contrast and resolution, Clarify DL optimises reconstruction without sacrificing image quality.
Aurora is also equipped with Effortless Workflow solutions, easing technologists’ tasks from pre-scan to post-scan with automation and design innovations.
The enhancements also improve patient comfort, particularly for those with high BMI.
University Hospitals department of radiology chair, radiologist-in-chief, and Ida and Irwin Haber and Wei-Shen Chin chair in radiology Donna Plecha said: “We are thrilled to be the first in the United States to adopt this incredibly impressive technology.
“Aurora’s seamless integration of SPECT and CT components will allow us to perform comprehensive, high-quality diagnostic exams in a single session, while its support of Clarify DL deep-learning image reconstruction enables enhanced image quality performance.”
The collaboration between University Hospital and GE HealthCare involves the purchase of Aurora SPECT/CT with Clarify DL, Effortless Workflow, and MIM Software solutions.
It focuses on implementing enterprise-wide technology to optimise workflows and improve clinical decision-making, ultimately benefiting patients and clinicians.
University Hospitals Ahuja Medical Centre chief operating officer Percival Kane said: “Patient flow and overall operational efficiency are crucial for us, making Aurora the ideal choice to help meet our needs.
“Additionally, we’re excited that Aurora’s Revolution Ascend CT technology matches what is used in our radiology department daily.”
